The U.S. government is demanding that Johnson & Johnson add another $800 million to an initial proposal to settle a federal civil investigation into marketing of the anti-psychotic drug Risperdal, Bloomberg reports.
According to Bloomberg, the Justice Department is demanding that the company pay about $1.8 billion to resolve the civil claims by the U.S. and some states.
The demand came after the Justice Department and states decided a $1 billion settlement that had been negotiated by the U.S. Attorney’s office in ...
continue reading...
Johnson & Johnson has announced that, beginning in October, bottles of Extra Strength Tylenol sold in the U.S. will be accompanied by new warnings and instructions. The warning will make it explicitly clear that the drug contains acetaminophen, a pain-relieving ingredient that is the nation’s leading cause of sudden liver failure. According to data from the Centers for Disease Control and Prevention and the Food and Drug ...
continue reading...
